TESTOSTERONE CYPIONATE-ESTRADIOL CYPIONATE

Post-LOE

estradiol cypionate; testosterone cypionate

Teva

ANDAINJECTIONINJECTABLE

Approved

Mar 1986

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

3/8 — Basic

TESTOSTERONE CYPIONATE-ESTRADIOL CYPIONATE (estradiol cypionate; testosterone cypionate) by Teva is clinical pharmacology endogenous estrogens are largely responsible for the development and maintenance of the female reproductive system and secondary sexual characteristics. Approved for the treatment of: 1. First approved in 1986.

Drug data last refreshed 18h ago

Mechanism of Action

CLINICAL PHARMACOLOGY Endogenous estrogens are largely responsible for the development and maintenance of the female reproductive system and secondary sexual characteristics. Although circulating estrogens exist in a dynamic equilibrium of metabolic interconversions, estradiol is the principal…

Worked on TESTOSTERONE CYPIONATE-ESTRADIOL CYPIONATE at Teva? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

TESTOSTERONE CYPIONATE-ESTRADIOL CYPIONATE

Mechanism of Action

Indications (1)